Go Deep
Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 21,696 | 36.6 | 5.30 | 0.06 | 1,846.40 |
| Sep 2026 | 21,595 | 37.0 | 5.36 | 0.06 | 1,867.10 |
| Sep 2026 | 21,737 | 36.5 | 5.28 | 0.06 | 1,838.00 |
| Sep 2026 | 21,737 | 36.5 | 5.28 | 0.06 | 1,838.00 |
| Sep 2026 | 21,737 | 36.8 | 5.28 | 0.06 | 1,838.00 |
| Sep 2026 | 21,737 | 36.8 | 5.28 | 0.06 | 1,838.00 |
| Oct 2026 | 21,741 | 35.7 | 5.17 | 0.06 | 1,801.00 |
| Oct 2026 | 21,136 | 34.9 | 5.05 | 0.06 | 1,760.00 |
Sun Pharmaceutical Industries Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 151,835,500,000.0 | 145,597,500,000.0 | 154,690,700,000.0 | 137,860,700,000.0 |
| Net Profit | 28,947,900,000.0 | 27,140,300,000.0 | 33,688,100,000.0 | 22,786,300,000.0 |
| EPS | 12.1 | 11.3 | 14.0 | 9.5 |
Sun Pharmaceutical Industries Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 582,201,100,000.0 | 520,412,500,000.0 | 477,584,500,000.0 | 432,788,700,000.0 |
| Net Profit | 114,794,200,000.0 | 109,290,400,000.0 | 95,763,800,000.0 | 84,735,800,000.0 |
| EPS | 47.8 | 45.6 | 39.9 | 35.3 |
Sun Pharmaceutical Industries Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,087,852,200,000.0 | 921,005,800,000.0 | 854,996,500,000.0 | 807,435,900,000.0 | — |
| Total Liabilities | 249,054,800,000.0 | 196,146,300,000.0 | 183,737,100,000.0 | 214,281,200,000.0 | — |
| Total Equity | 835,700,900,000.0 | 722,180,200,000.0 | 636,667,500,000.0 | 559,953,800,000.0 | — |
Owes vs Owns
Sun Pharmaceutical Industries Limited owed ₹0.23 for every ₹1 it owned in Mar 2026, down from ₹0.27 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.21× | 0.21× | 0.27× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Sun Pharmaceutical Industries Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 31.1%Receivables 14.3%Inventory 10.6%Fixed assets (tangible) 11.6%Intangible assets 21.5%Long-term investments 0.6%Other assets 10.4%
How it's funded — Mar 2026
Short-term debt 3.7%Payables 6.7%Other liabilities 12.4%Shareholders' equity 77.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 33,781.5 | 26,317.6 | 19,328.7 | 15,414.9 |
| Receivables | 15,509.7 | 13,046.1 | 11,249.4 | 11,438.5 |
| Inventory | 11,492.9 | 10,243.3 | 9,868.3 | 10,513.0 |
| Fixed assets (tangible) | 12,637.3 | 11,486.8 | 11,488.8 | 11,484.1 |
| Intangible assets | 23,379.2 | 17,960.0 | 17,302.0 | 17,684.9 |
| Long-term investments | 651.2 | 448.7 | 442.6 | 383.6 |
| Other assets | 11,333.4 | 12,598.1 | 15,819.9 | 13,824.5 |
| Liabilities & equity | ||||
| Short-term debt | 4,050.3 | 1,867.1 | 2,844.4 | 6,197.9 |
| Long-term debt | 31.3 | 2.5 | 1.3 | 0.0 |
| Payables | 7,333.8 | 6,184.3 | 5,653.3 | 5,681.5 |
| Other liabilities | 13,490.1 | 11,560.7 | 9,874.7 | 9,548.7 |
| Shareholders' equity | 83,879.7 | 72,485.9 | 67,125.9 | 59,315.5 |
| Net tangible assets | 60,190.8 | 54,258.1 | 46,364.8 | 38,310.5 |
Sun Pharmaceutical Industries Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating Activities | 124,191,800,000.0 | 140,720,900,000.0 | 121,349,800,000.0 | 49,593,300,000.0 |
| Investing Activities | -113,440,500,000.0 | -53,061,600,000.0 | -6,902,000,000.0 | -79,436,800,000.0 |
| Financing Activities | -25,125,500,000.0 | -79,058,200,000.0 | -67,101,600,000.0 | 23,760,700,000.0 |